Viracta Therapeutics Company

Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.

Total Funding: 184899999
Headquarters: Cardiff By The Sea, California, United States
Funding Status: IPO
Employee Number: 11-50
Estimated Revenue: $10M to $50M
Last Funding Type: Post-IPO Equity
Technology: Cancer
Investor Type: IPO
Last Funding Date: 2021
Investors Number: 19
Founded Date: 2007
Industry: Biopharma, Biotechnology, Medical, Pharmaceutical, Therapeutics